Luisa Gregori1, Arthur R Serer, Kristy L McDowell, Juraj Cervenak, David M Asher. 1. 1 Division of Emerging and Transfusion-Transmitted Diseases, Laboratory of Bacterial and Transmissible Spongiform Encephalopathy Agents, Center for Biologics Evaluation and Research, Office of Blood Research and Review, U.S. Food and Drug Administration, New Hampshire Avenue, Silver Spring, MD.
Abstract
BACKGROUND: Creutzfeldt-Jakob disease (CJD) has been accidentally transmitted by contaminated corneal transplants. Eye donors are not ordinarily tested for CJD, in part because an easy test is not available. We propose a relatively simple postmortem procedure to collect brain samples without performing full autopsy and show that a test currently marketed for veterinary diagnosis would offer an effective screening test. METHODS: We selected 6 brains from confirmed cases of human sporadic CJD and sampled each in triplicate (18 specimens), 28 control brains of individuals with non-CJD neurodegenerative diseases and 10 normal brains. We also applied a procedure involving retro-orbital puncture after enucleation and biopsied the frontal lobes and optic nerves of a macaque experimentally infected with variant CJD. All samples were tested with the IDEXX HerdChek BSE-Scrapie Ag Kit to detect the abnormal prion protein, PrP. RESULTS: The test discriminated between control and CJD-infected brains. All 18 infected brain samples diluted to 0.1%, except one, showed signals above cutoff, and a number of samples were reactive at even higher dilutions. These results suggest the test could detect the low concentrations of PrP probably present in brains of donors at early stages of CJD. Our collection procedure obtained sufficient macaque brain and optic nerve tissues to detect PrP. CONCLUSIONS: We showed that a commercial test combined with rapid sample collection might offer a practical solution to screen brains of cornea donors for evidence of CJD. Such a test might enhance safety of corneal transplants and some other tissue-derived products.
BACKGROUND: Creutzfeldt-Jakob disease (CJD) has been accidentally transmitted by contaminated corneal transplants. Eye donors are not ordinarily tested for CJD, in part because an easy test is not available. We propose a relatively simple postmortem procedure to collect brain samples without performing full autopsy and show that a test currently marketed for veterinary diagnosis would offer an effective screening test. METHODS: We selected 6 brains from confirmed cases of human sporadic CJD and sampled each in triplicate (18 specimens), 28 control brains of individuals with non-CJD neurodegenerative diseases and 10 normal brains. We also applied a procedure involving retro-orbital puncture after enucleation and biopsied the frontal lobes and optic nerves of a macaque experimentally infected with variant CJD. All samples were tested with the IDEXX HerdChek BSE-Scrapie Ag Kit to detect the abnormal prion protein, PrP. RESULTS: The test discriminated between control and CJD-infected brains. All 18 infected brain samples diluted to 0.1%, except one, showed signals above cutoff, and a number of samples were reactive at even higher dilutions. These results suggest the test could detect the low concentrations of PrP probably present in brains of donors at early stages of CJD. Our collection procedure obtained sufficient macaque brain and optic nerve tissues to detect PrP. CONCLUSIONS: We showed that a commercial test combined with rapid sample collection might offer a practical solution to screen brains of cornea donors for evidence of CJD. Such a test might enhance safety of corneal transplants and some other tissue-derived products.
Authors: Kristy L McDowell; Nabanita Nag; Zulmarie Franco; Ming Bu; Pedro Piccardo; Juraj Cervenak; Jean-Philippe Deslys; Emmanuel Comoy; David M Asher; Luisa Gregori Journal: Transfusion Date: 2014-08-25 Impact factor: 3.157
Authors: G A Wells; S A Hawkins; R B Green; A R Austin; I Dexter; Y I Spencer; M J Chaplin; M J Stack; M Dawson Journal: Vet Rec Date: 1998-01-31 Impact factor: 2.695
Authors: Jonathan D F Wadsworth; Susan Joiner; Jacqueline M Linehan; Melanie Desbruslais; Katie Fox; Sharon Cooper; Sabrina Cronier; Emmanuel A Asante; Simon Mead; Sebastian Brandner; Andrew F Hill; John Collinge Journal: Proc Natl Acad Sci U S A Date: 2008-03-03 Impact factor: 11.205
Authors: P Minor; J Newham; N Jones; C Bergeron; L Gregori; D Asher; F van Engelenburg; T Stroebel; M Vey; G Barnard; M Head Journal: J Gen Virol Date: 2004-06 Impact factor: 3.891
Authors: J E Fradkin; L B Schonberger; J L Mills; W J Gunn; J M Piper; D K Wysowski; R Thomson; S Durako; P Brown Journal: JAMA Date: 1991-02-20 Impact factor: 56.272
Authors: Daniela Meloni; Aart Davidse; Jan P M Langeveld; Katia Varello; Cristina Casalone; Cristiano Corona; Anne Balkema-Buschmann; Martin H Groschup; Francesco Ingravalle; Elena Bozzetta Journal: PLoS One Date: 2012-09-11 Impact factor: 3.240